The medical technology industry is becoming increasingly global, and innovation processes emphasize cost-effective health care solutions and translatable clinical outcomes. Rice University is preparing engineers to work in this new and changing environment with a focus on emerging markets.
The Rice University Department of Bioengineering expanded its non-thesis master of bioengineering (MBE) degree program through the launch of a unique track in Global Medical Innovation (GMI). Directed by Eric Richardson, Ph.D., the GMI program is designed to educate and train engineers for careers in medical technology through education in innovation, emerging-market design projects, and internships. The track builds on Rice’s top-ranked bioengineering programs, its award-winning design facilities at the Oshman Engineering Design Kitchen, the successful history of innovation in the developing world with Rice 360°: Institute for Global Health Technologies, and strong collaborations with the Texas Medical Center.
The GMI program specifically targets students who have an undergraduate degree in engineering (mechanical, electrical, chemical, or bioengineering/medical) or a related field, and who are interested in pursuing a career in the private, public, or non-profit sectors of medical technology.
The 2016-2017 GMI cohort began their global industry internship in June of 2016. They traveled to Costa Rica, where they spent two months collaborating with local universities and clinicians to develop design projects, then working as interns for Boston Scientific or St. Jude Medical. We invite you to read about their experiences here: gmi.rice.edu/student-blogs.
GMI will begin accepting accepting applications for the 2018-2019 academic year on September 1, 2017. For more information about the Global Medical Innovation MBE program, visit http://bioengineering.rice.edu/MBE.aspx. We’re also on Facebook at www.facebook.com/ricegmi.
Questions about the GMI track can be sent to email@example.com.